If you need more lookups,
subscriptions start at $34 USD/month.
Marc Mansour Location
Canada
Marc Mansour Work
2021 -now Chief Technology Officer @
2022 -now Vaccine Specialist and Advisor @
2019 -now President @ Avanda Biolabs Limited
2016 -now Strategic Advisor @ Infectious disease and cancer vaccines, Immunotherapy, Adjuvants and combination
2022 -2024 Cancer Vaccine Advisor @
2019 -2023 Strategic Business Development Advisor @ AELIX Therapeutics
2016 -2022 Chief Science and Business Officer @
2014 -2016 Chief Executive Officer @
2011 -2014 Chief Science Officer and Chief Operating Officer @
2006 -2010 VP Research and Development @
2001 -2006 Head Research Scientist @
Marc Mansour Education
Master's
MBA (Business Administration)
2008-2013
Doctorate
PhD (Biology)
1994-2002
Marc Mansour Skills
Immunology
Vaccines
Executive Management
Product Development
Clinical Development
Immunotherapy
Business Strategy
Oncology
Infectious Diseases
Pre-clinical R&D
Patents
Intellectual Property
R
Biotechnology
R&D
Research and Development (R&D)
Management
Pre Clinical R&d
Sales
Molecular Biology
Marketing
Research and Development R&d
Research and Development
Marc Mansour Summary
Marc Mansour, based in Canada, is currently a Chief Technology Officer at Virometix AG. Marc Mansour brings experience from previous roles at NEC Bio Therapeutics GmbH, Avanda Biolabs Limited, Infectious disease and cancer vaccines, Immunotherapy, Adjuvants and combination and NEC OncoImmunity AS. Marc Mansour holds a 2008 - 2013 MBA in Business Administration @ Master's. With a robust skill set that includes Immunology, Vaccines, Executive Management, Product Development, Clinical Development and more. Marc Mansour has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Marc Mansour?
Find contact details for 700 million professionals.